Publication
Article
Supplements and Featured Publications
Vice President
Analysis Group, Inc
Los Angeles, CA
Professor of Medicine
University of Toronto
Nephrologist
University Health Network
Toronto, Ontario Canada
Consultant
HEOR
Creativ-Ceutical S.À R.L.
Kraków, Poland
Vice President
Medical Affairs
Myriad Neuroscience
Mason, OH
Research Portfolio Manager, Research Strategy
Data Generation and Observational Studies
Bayer US, LLC
Whippany, NJ
Bayer AG
Pharmaceuticals
Digital & Commercial Innovation
HEOR CV
Wuppertal, Germany
LEDa[LEGOS]
Université Paris-Dauphine
PSL University
Paris, France
Bayer AG
Pharmaceuticals
Digital & Commercial Innovation
HEOR CV
Berlin, Germany
Vice President HEOR
Creativ-Ceutical S.À R.L.
Paris, France
Professor
Primary Care Unit
Department of Public Health and Primary Care
University of Cambridge
Cambridge, United Kingdom
Senior Analyst
HEOR
Creativ-Ceutical S.À R.L.
Kraków, Poland
Senior Principal
HEOR
Creativ-Ceutical S.À R.L.
Kraków, Poland
Professor of Medicine and Co-Director
University of North Carolina Kidney Center
Chapel Hill, NC
Staff Neurologist
Salisbury VA Medical Center
Salisbury, NC
Director, Data Generation and Observational Studies Research Strategy
Bayer US, LLC
Whippany, NJ
Vice President
Analysis Group, Inc
Los Angeles, CA
Dean and Professor
CHOICE Institute
School of Pharmacy
University of Washington
Seattle, WA
Senior Director, Medical-Market Access
Data Generation and Observational Studies
Bayer US, LLC
Whippany, NJ
Associate
Analysis Group, Inc
Los Angeles, CA
These faculty have disclosed the following relevant commercial financial relationships or affiliations in the past 12 months.
EMPLOYMENT
Analysis Group, Inc
INSTITUTIONAL CONFLICTS OF INTEREST
Analysis Group, Inc
CONSULTANCIES OR PAID ADVISORY BOARDS
Boehringer Ingelheim-Lilly, Merck, AstraZeneca, Sanofi, Mitsubishi-Tanabe, AbbVie, Janssen, Bayer, Prometic Pharma, Bristol Myers Squibb, Maze, Gilead, CSL-Behring, Otsuka, Novartis, Yeungene, and Novo Nordisk.
OPERATIONAL FUNDING FOR CLINICAL TRIALS
Boehringer Ingelheim-Lilly, Merck, Janssen, Sanofi, AstraZeneca, CSL-Behring, and Novo Nordisk.
EMPLOYMENT (AT TIME OF STUDY)
Bayer US, LLC
STOCK OWNERSHIP
Bayer
EMPLOYMENT
Bayer US, LLC
INSTITUTIONAL CONFLICTS OF INTEREST
Bayer US, LLC
EMPLOYMENT
Bayer AG
STOCK OWNERSHIP
Bayer AG
INSTITUTIONAL CONFLICTS OF INTEREST
Bayer AG
CONSULTANCIES OR PAID ADVISORY BOARDS
Bayer US, LLC
EMPLOYMENT
Bayer AG
INSTITUTIONAL CONFLICTS OF INTEREST
Bayer AG
STOCK OWNERSHIP
Bayer AG
INSTITUTIONAL CONFLICTS OF INTEREST
Creativ-Ceutical S.À R.L.
HONORARIA
Bayer AG
CONSULTANCIES OR PAID ADVISORY BOARDS
Creativ-Ceutical S.À R.L.
EMPLOYMENT
Inovasc LLC (CSO and Founder)
CONSULTANCIES OR PAID ADVISORY BOARDS
Akebia, Bayer, Cormedix, Humacyte, WL Gore, BD, Medtronic, and Vifor
EMPLOYMENT
Bayer US, LLC
INSTITUTIONAL CONFLICTS OF INTEREST
Bayer US, LLC
EMPLOYMENT
Analysis Group, Inc
INSTITUTIONAL CONFLICTS OF INTEREST
Analysis Group, Inc
CONSULTANCIES OR PAID ADVISORY BOARDS
Bayer US, LLC
EMPLOYMENT
Bayer US, LLC
INSTITUTIONAL CONFLICTS OF INTEREST
Bayer US, LLC
EMPLOYMENT
Analysis Group, Inc
INSTITUTIONAL CONFLICTS OF INTEREST
Analysis Group, Inc
Aleksandra Drzewiecka, MSc, and Monika Palarczyk, MSc, report no relationship or financial interest with any entity that would pose a conflict of interest with the subject matter of this supplement.